Bill Meury

Mr. Bill Meury is the President and Chief Executive Officer of Karuna Therapeutics and is also a member of the company’s Board of Directors. He is a distinguished pharmaceutical leader with more than 25 years of operational and commercial experience delivering transformative medicines to patients.

Mr. Meury joined Karuna from Hildred Capital Management, a private equity firm focusing on the healthcare industry, where he served as a partner. Prior to Hildred Capital Management, he was Executive Vice President and Chief Commercial Officer at Allergan, where he had responsibility for over 50 products with $16 billion in revenue and over $3 billion in marketing investment. In this role, he led multiple global divisions totaling over 7,500 employees, including marketing, sales, business analytics, marketing operations, managed care, pricing, and customer service. Mr. Meury has extensive experience in business development & licensing, R&D partnerships, and new product launches. In his prior roles he served as Allergan’s President, Branded Pharma, and Executive Vice President, Commercial, North American Brands. He also previously served as Executive Vice President, Sales and Marketing, at Forest Laboratories prior to its acquisition by Allergan. He currently serves on the board of directors of Syndax Pharmaceuticals and The Jed Foundation.

Mr. Meury received his bachelor’s degree in Economics from the University of Maryland.